Eledon PharmaceuticalsELDN
13F holders, Q1 2024 (March 31)29holders
3famous investors
$2.06avg. 13F price*
At the end of Q1 2024, 29 institutions reported holding Eledon Pharmaceuticals Inc. (ELDN) in their 13F filings. The largest holders were BVF Inc. ($8.9M), Armistice Capital, LLC ($4.7M) and Vanguard Group Inc. ($2.0M). 3 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Eledon Pharmaceuticals Inc.
- CUSIP
- 28617K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $156K |
| Exits | 3 | $26K |
Ownership 29 holders
| BVF Inc. | 0.24% | No change | 4,326,710 | $8.9M |
| Armistice Capital, LLC | 0.13% | Add +4.9% | 2,297,000 | $4.7M |
| Vanguard Group Inc. | 0.00% | Add +39.4% | 969,121 | $2.0M |
| Woodline Partners LP | 0.01% | Reduce -5.4% | 651,939 | $1.3M |
| Ensign Peak Advisors, Inc | 0.00% | No change | 443,001 | $913K |
| Geode Capital Management, LLC | 0.00% | Add +2.8% | 180,901 | $373K |
| CM Management, LLC | 0.28% | Add +14.3% | 160,000 | $330K |
| Susquehanna International Group, LLP | 0.00% | Add +15.6% | 99,778 | $206K |
| Renaissance Technologies | 0.00% | Add +25.9% | 87,069 | $179K |
| Jmac Enterprises LLC | 0.02% | No change | 58,041 | $120K |
| Ingalls & Snyder LLC | 0.00% | No change | 51,849 | $107K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 50,800 | $105K |
| State Street Corp. | 0.00% | No change | 44,692 | $92K |
| Northern Trust Corp. | 0.00% | Reduce -0.2% | 39,804 | $82K |
| BlackRock Inc. | 0.00% | Reduce -5.2% | 26,831 | $55K |
| Marco Investment Management LLC | 0.00% | New | 24,809 | $51K |
| Mercer Global Advisors Inc. | 0.00% | No change | 16,726 | $34K |
| Citadel Advisors | 0.00% | Reduce -31.1% | 15,982 | $33K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 14,987 | $31K |
| Millennium Management | 0.00% | Reduce -39.3% | 13,875 | $29K |
| Pathstone Holdings, LLC | 0.00% | No change | 13,029 | $27K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +0.7% | 5,674 | $12K |
| Morgan Stanley | 0.00% | No change | 2,155 | $4K |
| Wells Fargo & Company | 0.00% | Add +1.6% | 189 | $389 |
| JPMorgan Chase & Co. | 0.00% | Reduce -94.3% | 56 | $115 |
| Group One Trading LLC | 0.00% | No change | 22 | $45 |
| FMR LLC | 0.00% | New | 17 | $35 |
| UBS Group AG | 0.00% | Reduce -99.3% | 4 | $8 |
| Royal Bank of Canada | 0.00% | Reduce -63.0% | 40 | $0 |
"% of holder's portfolio" is ELDN's weight in each manager's 13F, not the share of Eledon Pharmaceuticals Inc. the manager owns.